PortViewPortView
Journey Medical logo

Journey Medical (DERM) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$7.59+0.26%
1-year price historyRange $4.39 – $9.26
52-week range$7.59
$4.31$9.56

What Journey Medical does

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

Key metrics

Market cap
$208.89M
P/E (TTM)
-20.51
EPS (TTM)
$-0.37
Beta
1.08
Dividend yield
0.00%
Revenue / share
$2.48
50-day avg
$6.87
200-day avg
$6.94
52-week high
$9.56
52-week low
$4.31
CEO
Claude Maraoui

ETFs linked to DERM

Broad-market and Healthcare sector ETFs an investor holding Journey Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DERM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze DERM in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Journey Medical?
Journey Medical trades under the ticker DERM on NASDAQ.
Which exchange is DERM listed on?
DERM is listed on NASDAQ.
What sector does Journey Medical operate in?
Journey Medical is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze DERM in a portfolio?
PortView shows DERM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.